Skip to content

Clinical trials

Completed Leukemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Status: Completed Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20092
20101
20111
20121
20131
20141
20152
20163
20174
20181
20192
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital3
Institute of Hematology & Blood Diseases Hospital, China2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2
AbbVie1
BeiGene1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Bristol-Myers Squibb1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia25
Leukemia, Myeloid, Acute5
Lymphoma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Hematologic Diseases2
Leukemia, Myeloid2
Philadelphia Chromosome2
Blastic Plasmacytoid Dendritic Cell Neoplasm1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.